Structures by: Nanubolu J. B.
Total: 135
C47H44BF2N3
C47H44BF2N3
The journal of physical chemistry. A (2020) 124, 47 9738-9750
a=13.5433(6)Å b=14.4891(7)Å c=20.4970(9)Å
α=90° β=105.986(2)° γ=90°
(E)-N'-(3,5-dichloro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9Cl2N3O2
IUCrJ (2017) 4, 6 812-823
a=8.0683(4)Å b=10.7464(6)Å c=15.6155(8)Å
α=90° β=90.890(2)° γ=90°
(E)-N'-(3,5-dichloro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9Cl2N3O2
IUCrJ (2017) 4, 6 812-823
a=15.441(3)Å b=8.3179(16)Å c=10.6014(18)Å
α=90° β=90° γ=90°
(E)-N'-(3,5-dichloro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9Cl2N3O2
IUCrJ (2017) 4, 6 812-823
a=8.6916(6)Å b=10.2641(7)Å c=15.4965(10)Å
α=90° β=90.186(2)° γ=90°
(E)-N'-(3,5-dibromo-2-hydroxybenzylidene)isonicotinohydrazide
C13H9Br2N3O2
IUCrJ (2017) 4, 6 812-823
a=8.266(2)Å b=10.917(2)Å c=15.734(3)Å
α=90.00(3)° β=95.82(3)° γ=90.00(3)°
(E)-N'-(3,5-dibromo-2-hydroxybenzylidene)isonicotinohydrazide
C13H9Br2N3O2
IUCrJ (2017) 4, 6 812-823
a=9.8084(7)Å b=10.7751(8)Å c=13.9516(9)Å
α=103.219(3)° β=94.907(3)° γ=91.018(3)°
(E)-N'-(3-bromo-5-chloro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9BrClN3O2
IUCrJ (2017) 4, 6 812-823
a=8.2475(9)Å b=10.8035(11)Å c=15.7971(15)Å
α=90° β=96.098(3)° γ=90°
(E)-N'-(3-bromo-5-chloro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9BrClN3O2
IUCrJ (2017) 4, 6 812-823
a=8.651(2)Å b=10.446(3)Å c=15.680(4)Å
α=90° β=94.116(11)° γ=90°
(E)-N'-(3,5-diiodo-2-hydroxybenzylidene)isonicotinohydrazide
C13H9I2N3O2
IUCrJ (2017) 4, 6 812-823
a=8.2946(5)Å b=11.2673(6)Å c=16.2177(10)Å
α=90° β=97.993(2)° γ=90°
(E)-N'-(3,5-difluoro-2-hydroxybenzylidene)isonicotinohydrazide
C13H9F2N3O2
IUCrJ (2017) 4, 6 812-823
a=7.897(2)Å b=10.396(2)Å c=14.989(3)Å
α=90.00(3)° β=92.27(3)° γ=90.00(3)°
3a-hydroxy-11a-methyl-10-phenyl-3,3a,11,11a-tetrahydro-1H-cyclopenta[4,5]pyrrolo[1,2-b]isoquinoline-1,5(2H)-dione
C22H19NO3
Chem. Sci. (2016)
a=18.7479(11)Å b=9.6392(6)Å c=19.3565(11)Å
α=90° β=90° γ=90°
Methyl 4-(4-nitrobenzoyloxy)biphenyl-2-carboxylate
C21H15NO6
Organic letters (2016) 18, 4 752-755
a=8.0698(9)Å b=6.5112(7)Å c=35.008(4)Å
α=90° β=92.980(2)° γ=90°
1:1 Cocrystal of Olanzapine and Resorcinol
C17H20N4S,C6H6O2
CrystEngComm (2020)
a=9.3190(5)Å b=11.5430(7)Å c=19.5648(12)Å
α=90° β=90.064(3)° γ=90°
1:1 Cocrystal of Olanzapine and Catechol
C17H20N4S,C6H6O2
CrystEngComm (2020)
a=25.972(5)Å b=9.1477(16)Å c=19.595(4)Å
α=90° β=107.679(8)° γ=90°
1:1:1 Cocrystal of Olanzapine, Hydroquinone and Benzene
C17H20N4S,C6H6O2,C6H6
CrystEngComm (2020)
a=9.0547(18)Å b=10.719(2)Å c=14.236(3)Å
α=80.860(5)° β=82.955(6)° γ=84.355(6)°
1:1:1 Cocrystal of Olanzapine, Hydroquinone and pXylene
C17H20N4S,C6H6O2,C8H10
CrystEngComm (2020)
a=9.3159(3)Å b=10.3802(4)Å c=15.0112(5)Å
α=96.2211(14)° β=90.7786(13)° γ=98.1870(13)°
1:1:2 Cocrystal of Olanzapine, Hydroquinone and Benzene
C17H20N4S,C6H6O2,2(C6H6)
CrystEngComm (2020)
a=9.1116(5)Å b=10.7195(7)Å c=15.8385(9)Å
α=88.452(2)° β=87.7422(17)° γ=82.8273(19)°
1:1:1:2 Cocrystal of Olanzapine, Hydroquinone, pXylene and Water
C17H20N4S,0.5(C6H6O2),0.5(C8H10),2(H2O)
CrystEngComm (2020)
a=28.1714(17)Å b=12.6444(7)Å c=14.0673(8)Å
α=90° β=104.3974(19)° γ=90°
1:1:1 Cocrystal of Olanzapine, Hydroquinone and Ethylbenzene
C17H20N4S,C6H6O2,C8H10
CrystEngComm (2020)
a=9.2694(12)Å b=10.3353(13)Å c=14.9174(19)Å
α=89.159(4)° β=86.632(4)° γ=82.387(4)°
C24H23NO
C24H23NO
RSC Advances (2020) 10, 27 15794-15799
a=6.1269(7)Å b=9.0770(12)Å c=17.366(2)Å
α=79.554(4)° β=84.737(4)° γ=81.243(5)°
C23H13ClF3N3O
C23H13ClF3N3O
Organic & biomolecular chemistry (2018) 16, 10 1720-1727
a=9.584(5)Å b=9.866(4)Å c=11.366(6)Å
α=80.384(9)° β=84.059(12)° γ=66.028(10)°
4-benzoyl-3-(dibenzo[b,d]thophen-4-yl)-8a-methyl-3,4,4a,5-tetrahydro-2H chromen-6(8a H)-one
C29H24O3S
Organic & biomolecular chemistry (2019) 17, 7 1937-1946
a=7.942(4)Å b=16.844(10)Å c=17.488(11)Å
α=90° β=90° γ=90°
5-(3-methoxyphenyl)-3-(methylsulfonyl)-2-(tosylmethyl)-3,4-dihydrobenzo[f]isoquinoline
C29H27NO5S2
Organic & biomolecular chemistry (2019) 17, 2 369-373
a=14.943(6)Å b=10.893(5)Å c=16.259(6)Å
α=90° β=90.199(10)° γ=90°
(Z)-(8-methoxy-4H-benzo[g][1,2,3]triazolo[5,1-c][1,4]oxazocin-11-yl)(phenyl)methanone
C19H15N3O3
Organic & biomolecular chemistry (2016) 14, 39 9294-9305
a=6.5491(5)Å b=18.5820(13)Å c=12.9625(9)Å
α=90° β=93.3610(10)° γ=90°
(4S)-4-(4-chlorobenzoyl)-2-methylhexahydropyrrolo[3,4-a]pyrrolizine-1,3(2H,4H)-dione
C17H17ClN2O3
Organic & biomolecular chemistry (2017) 15, 13 2730-2733
a=12.4653(16)Å b=8.3351(11)Å c=16.192(2)Å
α=90° β=110.902(2)° γ=90°
2,10-dimethyl-3-nitro-10H-pyrazolo[1',5':1,6]pyrido[2,3-b]indole
C15H12N4O2
Organic & biomolecular chemistry (2015) 13, 30 8232-8240
a=7.1508(10)Å b=9.6154(14)Å c=10.0654(14)Å
α=82.965(2)° β=70.019(2)° γ=87.230(2)°
Ethyl 2-((p-tolylsulfinyl)amino)-2-(5,6,7-trimethoxy-2-methyl-1H-inden-3-yl)acetate
C24H29NO6S
Organic & biomolecular chemistry (2015) 13, 33 8875-8885
a=10.3258(9)Å b=17.5826(15)Å c=13.7351(12)Å
α=90.00° β=101.7890(10)° γ=90.00°
2-methyl-3-nitropyrazolo[1,5-a]quinoline
C12H9N3O2
Organic & biomolecular chemistry (2015) 13, 30 8232-8240
a=7.4947(11)Å b=13.0618(18)Å c=21.098(3)Å
α=90.00° β=90.00° γ=90.00°
(E)-3-chloro-4-(4-chlorophenyl)-7,7-dimethyl-5-oxo-2-((phenylthio)imino)-3,4,5,6,7,8-hexahydro-2H-chromene-3-carbonitrile
C24H20Cl2N2O2S
Organic & biomolecular chemistry (2015) 14, 2 582-589
a=16.6008(8)Å b=13.5612(7)Å c=21.8151(11)Å
α=90° β=106.9260(10)° γ=90°
Methyl 2,2-dihydroxy-2-(5-oxotetrahydrofuran-2-yl)acetate
C7H10O6
Organic & biomolecular chemistry (2014) 12, 30 5601-5610
a=6.7699(4)Å b=8.2068(5)Å c=15.1001(9)Å
α=90.00° β=90.00° γ=90.00°
Methyl 3-(4-chlorophenyl)-2-cyano-2,3-dihydronaphtho[1,2-b]furan-2-carbimidate
C21H15ClN2O2
Organic & biomolecular chemistry (2014) 12, 25 4412-4420
a=8.8826(8)Å b=9.7822(8)Å c=20.8708(18)Å
α=90.00° β=90.00° γ=90.00°
Dimethyl 3-phenylnaphtho[1,2-b]furan-2,2(3H)-bis(carbimidate)
C22H20N2O3
Organic & biomolecular chemistry (2014) 12, 25 4412-4420
a=15.9828(14)Å b=6.8208(6)Å c=34.232(3)Å
α=90.00° β=90.00° γ=90.00°
Methyl 4''-(tert-butyl)-6'-(methylthio)-[1,1':3',1''-terphenyl]-4'-carboxylate
C25H26O2S
Chemical communications (Cambridge, England) (2020) 56, 87 13457-13460
a=10.361(5)Å b=22.362(10)Å c=10.254(4)Å
α=90° β=113.650(8)° γ=90°
C26H26N2O4S2
C26H26N2O4S2
Chemical Communications (2020)
a=16.1653(14)Å b=8.6116(7)Å c=18.7980(16)Å
α=90° β=111.5570(10)° γ=90°
C21H24N2O4S2
C21H24N2O4S2
Chemical Communications (2020)
a=12.745(3)Å b=8.2887(17)Å c=20.697(4)Å
α=90° β=104.665(3)° γ=90°
Methyl 3-(1-oxo-1,3,4,9-tetrahydro-2H-pyrido[3,4-b]indol-2-yl)propanoate
C15H16N2O3
Chemical communications (Cambridge, England) (2020) 56, 18 2803-2806
a=12.777(8)Å b=5.986(3)Å c=17.896(7)Å
α=90° β=93.909(15)° γ=90°
Bis(2-naphthoxy)phosphorus(V)- tris 5,10,15-(pentafluorophenyl) corrole
C57H22F15N4O2P
New Journal of Chemistry (2018) 42, 10 8230
a=22.2000(15)Å b=15.2908(10)Å c=27.5057(19)Å
α=90° β=95.4730(10)° γ=90°
4-(4-chlorophenyl)-2-(5-(4-chlorophenyl)-1H-pyrazol-1-yl) thiazole
C18H11Cl2N3S
New J. Chem. (2017)
a=7.3400(7)Å b=18.9644(18)Å c=23.232(2)Å
α=90° β=90° γ=90°
(E)-2-cyano-3-phenylacrylamide
C10H8N2O
New J. Chem. (2017)
a=10.498(2)Å b=11.412(3)Å c=17.061(3)Å
α=90° β=114.079(10)° γ=90°
C15H17ClOS2
C15H17ClOS2
New J. Chem. (2017)
a=5.8350(4)Å b=8.6412(6)Å c=15.4578(10)Å
α=85.6620(10)° β=83.5850(10)° γ=86.6520(10)°
Ethyl 5-methyl-4-oxo-4,5-dihydro-3H-pyrrolo[2,3-c]quinoline-1-carboxylate
C15H14N2O3
RSC Advances (2019) 9, 60 35068
a=6.063(4)Å b=9.023(7)Å c=11.915(8)Å
α=96.04(3)° β=90.884(19)° γ=90.83(2)°
4-(4-ethylphenyl)-2-phenyl-3-thioxo-2,3-dihydro-1H-pyrrolo[3,4-c] quinolin-1-one
C25H18N2OS
RSC Advances (2013) 3, 43 20990
a=4.2876(5)Å b=19.102(2)Å c=23.711(3)Å
α=90.00° β=90.00° γ=90.00°
Cytosinium-3,5-dinitrobenzoate trihydrate
C4H6N3O,C7H3N2O6,3(H2O)
CrystEngComm (2012) 14, 20 7065
a=5.0257(3)Å b=24.5327(15)Å c=13.1664(8)Å
α=90.00° β=90.462(1)° γ=90.00°
Cytosinium para amino benzoate cytosine monohydrate
C4H6N3O,C7H6NO2,C4H5N3O,H2O
CrystEngComm (2012) 14, 20 7065
a=7.3666(3)Å b=6.4615(3)Å c=36.9629(16)Å
α=90.00° β=94.462(1)° γ=90.00°
Cytosinium 4-hydroxyphenylacetate cytosine monohydrate
C4H6N3O,C8H7O3,C4H5N3O,H2O
CrystEngComm (2012) 14, 20 7065
a=14.9164(10)Å b=12.3456(8)Å c=19.9754(13)Å
α=90.00° β=90.00° γ=90.00°
Cytosinium-2,5-dihydroxybenzoate
C4H6N3O,C7H5O4
CrystEngComm (2012) 14, 20 7065
a=10.1137(8)Å b=8.5120(7)Å c=13.9992(12)Å
α=90.00° β=110.610(1)° γ=90.00°
4N-((7-hydroxy-2-oxo-4-(trifluoromethyl)-2H-chromen-8-yl) (4-methoxyphenyl)methyl)acetamide
C20H16F3NO5
RSC Advances (2014) 4, 28 14501
a=14.8017(10)Å b=13.8173(9)Å c=17.9104(12)Å
α=90.00° β=90.00° γ=90.00°
Diphenyl(3-(pyren-1-yl-)phenyl)phosphine oxide
C34H23OP
Journal of Materials Chemistry C (2015) 3, 1208-1224
a=9.0088(9)Å b=9.6445(9)Å c=14.0042(13)Å
α=96.309(2)° β=98.1750(10)° γ=92.359(2)°
7-chloro-4-(4-methoxyphenyl)-1-(methylsulfonyl)-2-(tosylmethyl)-1H-benzo[b]azepine
C26H24ClNO5S2
Chemical communications (Cambridge, England) (2016) 52, 26 4824-4827
a=9.7246(6)Å b=11.0418(6)Å c=12.8181(7)Å
α=70.8320(10)° β=71.9300(10)° γ=88.3310(10)°
(E)-4-(4-methoxyphenyl)-1-(methylsulfonyl)-2-(tosylmethylene)-2,3-dihydro-1H-benzo[b]azepine
C26H25NO5S2
Chemical communications (Cambridge, England) (2016) 52, 26 4824-4827
a=13.9256(9)Å b=10.3322(7)Å c=17.0868(11)Å
α=90° β=94.6470(10)° γ=90°
C22H14ClNO
C22H14ClNO
Chem. Commun. (2017)
a=11.8090(9)Å b=13.9475(11)Å c=10.4695(8)Å
α=90° β=93.4770(10)° γ=90°
4-((1-(2-Fluorophenyl)vinyl)oxy)-2-phenylquinazoline
C22H15FN2O
Chemical communications (Cambridge, England) (2017) 53, 10 1672-1675
a=38.444(4)Å b=6.2239(6)Å c=14.5234(13)Å
α=90° β=96.834(3)° γ=90°
Dutasteride hemihydrate
2(C27H30F6N2O2),H2O
CrystEngComm (2012) 14, 7 2571
a=8.2124(7)Å b=18.5162(17)Å c=34.876(3)Å
α=90.00° β=90.00° γ=90.00°
Dutasteride chloride hydrate ethanol solvate
C27H31F6N2O2,Cl,H2O,C2H6O
CrystEngComm (2012) 14, 7 2571
a=7.9357(7)Å b=9.1050(8)Å c=11.1952(9)Å
α=73.7460(10)° β=88.6870(10)° γ=86.1930(10)°
5-bromo-3-hydroxy 3-(3-oxopentylindolin-2-one
C13H14BrNO3
RSC Adv. (2015)
a=7.5781(13)Å b=13.148(2)Å c=14.903(3)Å
α=71.939(3)° β=78.573(4)° γ=82.292(4)°
1:1 cocrystal of Aripiprazole Phloroglucinol Hydrate
C23H27Cl2N3O2,C6H6O3,O
CrystEngComm (2016) 18, 6 1024
a=14.8405(6)Å b=10.2671(4)Å c=20.6587(9)Å
α=90° β=110.2190(10)° γ=90°
1:1 cocrystal of Aripiprazole Catechol Hydrate
C23H27Cl2N3O2,C6H6O2,0.293(O)
CrystEngComm (2016) 18, 6 1024
a=14.7513(16)Å b=9.9206(11)Å c=20.9131(17)Å
α=90° β=111.104(6)° γ=90°
1:1 cocrystal of Aripiprazole and Hydroquinone
C23H27Cl2N3O2,C6H6O2
CrystEngComm (2016) 18, 6 1024
a=6.9061(8)Å b=9.4544(11)Å c=22.484(3)Å
α=96.056(2)° β=95.355(2)° γ=100.696(2)°
1:1 cocrystal of Aripiprazole Pyrograllol Hydrate
C23H27Cl2N3O2,C6H6O3,0.256(O)
CrystEngComm (2016) 18, 6 1024
a=14.7016(11)Å b=9.9378(7)Å c=20.9827(12)Å
α=90° β=111.121(4)° γ=90°
(2Z)-N,3-dibutyl-4-(2-oxo-2H-chromen-3-yl)-2,3- dihydro-1,3-thiazol-2-iminium bromide
C20H25N2O2S,Br
RSC Adv. (2015)
a=11.7828(8)Å b=11.0859(7)Å c=16.1335(10)Å
α=90.00° β=93.1990(10)° γ=90.00°
2,2'-(3-(4-chlorophenyl)-3-oxopropane-1, 1-diyl) bis (3-hydroxy-5, 5-dimethylcyclohex-2-enone)
C25H29ClO5
RSC Adv. (2015) 5, 129 106860
a=19.0793(11)Å b=11.3954(7)Å c=22.0551(13)Å
α=90.00° β=98.7630(10)° γ=90.00°
3,3,9,9-tetramethyl-6-phenyl-3,4,8,9,10,12-hexahydro-1H-6,12-methanodibenzo[d,g][1,3]dioxocine-1,11(2H)-dione
C25H28O4
RSC Adv. (2015) 5, 129 106860
a=5.7508(11)Å b=10.2102(19)Å c=10.3282(19)Å
α=60.929(2)° β=80.487(3)° γ=76.750(3)°
9-(pyrimidin-2-yl)-1-(p-tolyl)-9H-carbazole
C23H17N3
RSC Adv. (2016)
a=9.5942(6)Å b=11.3101(7)Å c=16.4330(10)Å
α=90.00° β=96.6930(10)° γ=90.00°
4-(4-chlorobenzoyl)-5-(methylthio)-thiophen-2(2H)-one
C12H9ClO2S2
RSC Adv. (2015)
a=12.2624(8)Å b=13.4433(9)Å c=7.9968(5)Å
α=90.00° β=106.1680(10)° γ=90.00°
4-(4-ethylbenzoyl)-5-(methylthio)thiophen-2,3-dione
C14H12O3S2
RSC Adv. (2015)
a=5.7321(15)Å b=8.788(2)Å c=13.769(4)Å
α=99.381(5)° β=101.216(4)° γ=90.696(4)°
4a-hydroxy 3,3-dimethy-l 2,3,4,4a-tetrhydro-1H-benzo[b]xanthen-1-one
C19H18O3
RSC Adv. (2015)
a=11.6133(8)Å b=6.8128(5)Å c=20.3843(13)Å
α=90.00° β=108.514(3)° γ=90.00°
1:1 cocrystal of Aripiprazole Resorcinol
C23H27Cl2N3O2,C6H6O2
CrystEngComm (2016) 18, 6 1024
a=14.7282(12)Å b=9.8820(8)Å c=20.8815(14)Å
α=90° β=111.174(5)° γ=90°
Olanzapine-hydroquinone-toluene form II
C17H20N4S,C6H6O2,C7H8
CrystEngComm (2017) 19, 2 355
a=9.3202(10)Å b=10.5724(12)Å c=14.7777(16)Å
α=88.561(2)° β=85.685(2)° γ=81.729(2)°
Olanzapine-hydroquinone-toluene form I
C17H20N4S,C6H6O2,C7H8
CrystEngComm (2017) 19, 2 355
a=10.6675(14)Å b=11.6121(15)Å c=13.0639(17)Å
α=72.725(2)° β=74.290(2)° γ=65.743(2)°
1:2 salt of 2-(4-bromophenyl)-4-imino-4,1b-dihydro-1H-pyrido[2,1-a]isoquinoline-3-carbonitrile and trifluoroacetic acid
C20H13BrN3,C2F3O2,C2HF3O2
RSC Adv. (2015)
a=11.8210(7)Å b=15.0720(9)Å c=14.4847(9)Å
α=90.00° β=109.6100(10)° γ=90.00°
4-(3,6-di-tert-butylcarbazol-9-yl)-N,N-bis(4-{[1,2,5]thiadiazolo[3,4-b]pyridin-6-yl}phenyl)aniline
C48H40N8S2
RSC Adv. (2016)
a=12.4586(9)Å b=14.8169(10)Å c=15.6249(11)Å
α=110.3700(10)° β=99.7720(10)° γ=112.0440(10)°
C22H19NO2
C22H19NO2
RSC Adv. (2015) 5, 36 28597
a=8.4025(6)Å b=8.9518(6)Å c=22.4061(15)Å
α=90.00° β=90.00° γ=90.00°
(1'S,2'S,3S,7a'S)-1'-(4-nitrophenyl)-2'-(4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)-1',2',5',6',7',7a'-hexahydrospiro[indoline-3,3'-pyrrolizin]-2-one
C34H27N5O4
RSC Advances (2014)
a=15.9316(13)Å b=11.8821(10)Å c=15.2579(12)Å
α=90.00° β=103.5740(10)° γ=90.00°
Aripiprazole hydrochloride salt
C23H28Cl2N3O2,Cl
CrystEngComm (2013) 15, 21 4321
a=10.2891(12)Å b=28.065(3)Å c=7.9247(9)Å
α=90.00° β=90.885(2)° γ=90.00°
Aripiprazole benzoate monohydrate
C23H28Cl2N3O2,C7H5O2,H2O
CrystEngComm (2013) 15, 21 4321
a=14.9688(10)Å b=9.9536(6)Å c=20.9154(14)Å
α=90.00° β=108.0040(10)° γ=90.00°
Aripiprazole-2,4-dihydoxybenzoate
C23H28Cl2N3O2,C7H5O4
CrystEngComm (2013) 15, 21 4321
a=15.1552(8)Å b=9.5732(5)Å c=21.5283(11)Å
α=90.00° β=103.8870(10)° γ=90.00°
Aripiprazole-2,5-dihydroxybenzoate hemihydrate
2(C23H28Cl2N3O2),2(C7H5O4),H2O
CrystEngComm (2013) 15, 21 4321
a=30.4165(19)Å b=9.7801(6)Å c=20.5636(13)Å
α=90.00° β=105.3190(10)° γ=90.00°
(C23H14O62),2(C4H12N5)
(C23H14O62),2(C4H12N5)
CrystEngComm (2013) 15, 22 4448
a=17.8097(8)Å b=7.9282(4)Å c=25.8018(9)Å
α=90.00° β=119.499(2)° γ=90.00°
2(C4H12N5),C23H14O62
2(C4H12N5),C23H14O62
CrystEngComm (2013) 15, 22 4448
a=7.4680(6)Å b=13.8016(11)Å c=16.2856(13)Å
α=73.334(1)° β=83.171(1)° γ=82.666(1)°
(E)-methyl-3-(5-methoxybenzofuran-2-yl)acrylate
C14H14O4
RSC Adv. (2014)
a=8.0907(15)Å b=8.1765(15)Å c=10.6283(19)Å
α=91.440(3)° β=101.366(3)° γ=114.809(3)°
3,5-diphenyl-1-(trifluoromethyl)-3,11-dihydro-5,11-methanobenzo[7,8][1,3]dioxocino[4,5-c]pyrazole
C25H17F3N2O2
RSC Advances (2014)
a=12.4985(13)Å b=9.3025(9)Å c=18.0441(18)Å
α=90.00° β=90.754(2)° γ=90.00°
2-(4-methoxybenzoyl)-3-(4-nitrophenyl)spiro[cyclopropane-1,3'-indolin]-2'-one
C24H18N2O5
RSC Advances (2014)
a=10.2802(8)Å b=11.3015(9)Å c=18.0590(14)Å
α=90.00° β=104.2340(10)° γ=90.00°
Ethyl3-(4-bromophenyl)-2-cyano-6,6-dimethyl-4-oxo- 2,3,4,5,6,7-hexahydrobenzofuran-2-carboxylate
C20H20BrNO4
Green Chemistry (2014) 16, 6 3237
a=10.7001(8)Å b=11.3758(8)Å c=17.0795(12)Å
α=90.00° β=103.6200(10)° γ=90.00°
3-(4-bromophenyl)-2-cyano-6,6-dimethyl-4-oxo- 2,3,4,5,6,7-hexahydro-1-benzofuran-2-carboxamide
C18H18N2O3
Green Chemistry (2014) 16, 6 3237
a=11.2762(7)Å b=13.0441(8)Å c=12.5041(7)Å
α=90.00° β=112.6690(10)° γ=90.00°
7-(4-(4-(2,3-dichlorophenyl)-1-piperazinyl)butoxy)-3,4- dihydrocarbostyril)
C23H27Cl2N3O2
CrystEngComm (2012) 14, 14 4677
a=12.2626(7)Å b=13.7872(8)Å c=14.7405(9)Å
α=101.396(1)° β=108.921(1)° γ=98.847(1)°
Deferiprone
C7H9NO2
Acta Crystallographica Section C (2020) 76, 2 193-200
a=7.185(3)Å b=12.917(6)Å c=13.697(6)Å
α=90° β=90° γ=90°
Deferiprone
C7H9NO2
Acta Crystallographica Section C (2020) 76, 2 193-200
a=6.48470(10)Å b=13.6853(3)Å c=7.14620(10)Å
α=90° β=95.6583(8)° γ=90°
Deferiprone
C7H9NO2
Acta Crystallographica Section C (2020) 76, 2 193-200
a=19.4132(8)Å b=13.7057(7)Å c=7.1809(7)Å
α=90° β=91.7750(10)° γ=90°
<i>tert</i>-Butyl 4'-(4-bromophenyl)-1''-methyl-2,2''-dioxo-5'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-1-carboxylate
C36H31BrN2O5
Acta Crystallographica Section C (2015) 71, 8
a=9.5268(12)Å b=13.0566(17)Å c=13.4593(17)Å
α=94.401(2)° β=97.385(2)° γ=107.762(2)°
5'-(4-Bromophenyl)-1,1''-dimethyl-4'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C32H25BrN2O3
Acta Crystallographica Section C (2015) 71, 8
a=9.0986(7)Å b=9.7185(7)Å c=16.5056(13)Å
α=78.9150(10)° β=75.7630(10)° γ=67.6870(10)°
<i>tert</i>-Butyl 1''-methyl-2,2''-dioxo-4'-phenyl-5'-(<i>p</i>-tolyl)-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-1-carboxylate
C37H34N2O5
Acta Crystallographica Section C (2015) 71, 8
a=10.1226(9)Å b=14.3682(13)Å c=21.353(2)Å
α=90° β=91.799(2)° γ=90°
Methyl 3a-acetyl-3-(4-bromophenyl)-4-oxo-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>-furo[3,4-<i>c</i>]chromene-1-carboxylate benzene monosolvate
C27H21BrO6,C6H6
Acta Crystallographica Section C (2017) 73, 5 407-413
a=8.4269(6)Å b=12.4905(8)Å c=15.1415(10)Å
α=66.5300(10)° β=76.0050(10)° γ=85.4730(10)°
Methyl 3a-acetyl-3-(4-bromophenyl)-4-oxo-1-phenyl-3,3a,4,9b-tetrahydro-1<i>H</i>-furo[3,4-<i>c</i>]chromene-1-carboxylate toluene monosolvate
C27H21BrO6,C7H8
Acta Crystallographica Section C (2017) 73, 5 407-413
a=8.3989(5)Å b=12.5415(7)Å c=15.2195(8)Å
α=67.4080(10)° β=76.1350(10)° γ=85.4580(10)°
1,1''-Dibenzyl-5'-(4-chlorophenyl)-4'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C44H33ClN2O3
Acta Crystallographica Section C (2015) 71, 11
a=10.1099(10)Å b=11.3367(11)Å c=17.0315(17)Å
α=74.755(2)° β=78.503(2)° γ=65.557(2)°
1''-Acetyl-1-benzyl-5'-(4-chlorophenyl)-4'-phenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C39H29ClN2O4
Acta Crystallographica Section C (2015) 71, 11
a=11.9830(5)Å b=12.9260(6)Å c=21.5664(10)Å
α=76.3300(10)° β=76.5220(10)° γ=77.5530(10)°
1''-Acetyl-1-benzyl-4',5'-diphenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione
C39H30N2O4
Acta Crystallographica Section C (2015) 71, 11
a=9.7565(10)Å b=16.6868(16)Å c=19.9593(19)Å
α=71.653(2)° β=81.657(2)° γ=89.314(2)°
1''-Acetyl-1-benzyl-4',5'-diphenyl-4',5'-dihydrodispiro[indoline-3,2'-furan-3',3''-indoline]-2,2''-dione acetonitrile hemisolvate
C39H30N2O4,0.5(C2H3N)
Acta Crystallographica Section C (2015) 71, 11
a=9.6940(5)Å b=18.5810(10)Å c=20.1552(11)Å
α=114.872(2)° β=98.465(2)° γ=99.397(2)°
Thymine--pyrogallol (1/2)
C5H6N2O2,2(C6H6O3)
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=6.9652(13)Å b=10.2125(19)Å c=12.951(2)Å
α=97.218(3)° β=99.189(3)° γ=108.549(3)°
Thymine--hydroquinone (2/1)
2(C5H6N2O2),C6H6O2
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=14.204(3)Å b=6.9634(13)Å c=8.4505(15)Å
α=90° β=97.639(3)° γ=90°
Thymine--catechol (2/1)
2(C5H6N2O2),C6H6O2
Acta Crystallographica Section C Structural Chemistry (2015) 71, 7 602
a=6.9499(7)Å b=9.0237(10)Å c=26.828(3)Å
α=90° β=90° γ=90°